SIMPLEX TRADING, LLC - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is G8807B906. A total of 2 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$366
+152.4%
42,500
+201.4%
0.00%
Q2 2023$145
-81.9%
14,100
-80.9%
0.00%
-100.0%
Q1 2023$802
-39.7%
74,000
-37.7%
0.00%0.0%
Q4 2022$1,331
-99.9%
118,700
+29.9%
0.00%0.0%
Q3 2022$926,000
+2623.5%
91,400
+2305.3%
0.00%
Q2 2022$34,000
-54.7%
3,800
-51.9%
0.00%
Q1 2022$75,000
-69.3%
7,900
-64.3%
0.00%
Q4 2021$244,000
+639.4%
22,100
+860.9%
0.00%
Q3 2021$33,0000.0%2,3000.0%0.00%
Q2 2021$33,000
+37.5%
2,300
+19066.7%
0.00%
Q1 2021$24,000
-45.5%
12
-60.0%
0.00%
Q3 2020$44,000
+25.7%
30
+76.5%
0.00%
Q2 2020$35,000
-70.1%
17
-66.7%
0.00%
Q1 2020$117,000
-14.6%
51
-3.8%
0.00%
Q4 2019$137,000
+1612.5%
53
+960.0%
0.00%
Q2 2019$8,000
+300.0%
5
+400.0%
0.00%
Q4 2018$2,000
-66.7%
1
-50.0%
0.00%
Q3 2018$6,0000.0%2
-33.3%
0.00%
Q2 2018$6,000
+200.0%
3
-81.2%
0.00%
Q4 2017$2,000
-81.8%
16
-5.9%
0.00%
Q3 2017$11,000
+37.5%
17
+30.8%
0.00%
Q2 2017$8,000
+14.3%
130.0%0.00%
Q1 2017$7,0000.0%13
-51.9%
0.00%
Q4 2016$7,00027
+170.0%
0.00%
Q2 2016$010
-61.5%
0.00%
Q1 2016$026
+2500.0%
0.00%
Q4 2015$010.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 3,900$69,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of THERAVANCE BIOPHARMA INC shareholders